119 related articles for article (PubMed ID: 12408102)
21. [Tenofovir (Viread)].
Sidahora; 2002; (1):20-1. PubMed ID: 12772661
[No Abstract] [Full Text] [Related]
22. Tenofovir: FDA hearing on important new antiretroviral.
James JS
AIDS Treat News; 2001 Oct; (372):2-4. PubMed ID: 11702411
[No Abstract] [Full Text] [Related]
23. Tenofovir--long term results from first-line therapy.
TreatmentUpdate; 2003; 15(2):4-6. PubMed ID: 12693361
[No Abstract] [Full Text] [Related]
24. Tenofovir DF trial announced by Gilead.
Eagan L
Posit Living; 2000 Jul; 9(6):22, 54. PubMed ID: 12492018
[No Abstract] [Full Text] [Related]
25. Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.
de Vries-Sluijs TE; van der Eijk AA; Hansen BE; Osterhaus AD; de Man RA; van der Ende ME
J Clin Virol; 2006 May; 36(1):60-3. PubMed ID: 16418013
[TBL] [Abstract][Full Text] [Related]
26. Tenofovir: FDA hearing October 3, public comment deadlines September 26.
James JS
AIDS Treat News; 2001 Aug; (370):3-4. PubMed ID: 11570163
[No Abstract] [Full Text] [Related]
27. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Reijnders JG; Janssen HL
J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
[No Abstract] [Full Text] [Related]
28. Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients.
Masquelier B; Neau D; Boucher S; Lavignolle-Aurillac V; Schrive MH; Recordon-Pinson P; Ragnaud JM; Fleury H
Antivir Ther; 2006; 11(6):827-30. PubMed ID: 17310827
[TBL] [Abstract][Full Text] [Related]
29. Tenofovir DF on the horizon. Investigational nucleotide reverse transcriptor inhibitor could be on pharmacy shelves soon.
Eagan L
Posit Living; 2001; 10(5):21. PubMed ID: 11693102
[No Abstract] [Full Text] [Related]
30. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir.
Sheldon J; Camino N; Rodés B; Bartholomeusz A; Kuiper M; Tacke F; Núñez M; Mauss S; Lutz T; Klausen G; Locarnini S; Soriano V
Antivir Ther; 2005; 10(6):727-34. PubMed ID: 16218172
[TBL] [Abstract][Full Text] [Related]
31. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
[TBL] [Abstract][Full Text] [Related]
32. French investigators warn of LPV/TDF/ddI interaction.
Carter M
IAPAC Mon; 2003 Dec; 9(12):315. PubMed ID: 15055164
[No Abstract] [Full Text] [Related]
33. Tenofovir approved: broad indication.
James JS
AIDS Treat News; 2001 Oct; (373):2-3. PubMed ID: 11768879
[No Abstract] [Full Text] [Related]
34. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
[TBL] [Abstract][Full Text] [Related]
35. Failure of combination abacavir + tenofovir + lamivudine (3TC).
AIDS Treat News; 2003 Jul; (393):2. PubMed ID: 14679923
[TBL] [Abstract][Full Text] [Related]
36. Would switching the protease inhibitors (PI) to tenoforvir be an option in controlling hypertriglyceridaemia secondary to PIs? A case report.
Alcaide ML; Kolber M; Jayaweera D
Int J STD AIDS; 2002 Nov; 13(11):795-6. PubMed ID: 12437905
[No Abstract] [Full Text] [Related]
37. New uses for tenofovir: more questions about d4T.
Proj Inf Perspect; 2003 Jan; (35):15-6. PubMed ID: 12647676
[TBL] [Abstract][Full Text] [Related]
38. Atazanavir (Reyataz): new recommendations if combined with tenofovir (Viread) -- and warning on Viagra, Cialis, and Levitra.
AIDS Treat News; 2004 Mar; (399):5. PubMed ID: 15199867
[TBL] [Abstract][Full Text] [Related]
39. Tenofovir (Viread(R)) access for poor countries.
James JS
AIDS Treat News; 2002 Dec; (386):6-7. PubMed ID: 12569875
[TBL] [Abstract][Full Text] [Related]
40. Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen.
Tamalet C; Tomei C; Henry M; Solas C; Villacian J; Colson P
AIDS; 2007 Nov; 21(18):2551-2. PubMed ID: 18025898
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
